![David Hyman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Dr. David Hyman, MD, is a Chief Medical Officer at Eli Lilly & Co. and a Chief Medical Officer at Loxo Oncology, Inc.
Cargos activos de David Hyman
| Empresas | Cargo | Inicio |
|---|---|---|
| LOXO ONCOLOGY INC | Director Técnico/Científico/I+D | 01/01/2020 |
| ELI LILLY AND COMPANY | Director Técnico/Científico/I+D | 16/10/2023 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
64
Relaciones de 1er grado
2
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Loxo Oncology, Inc.
 Loxo Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicine for cancer treatment | Health Technology |
- Bolsa de valores
- Insiders
- David Hyman
